NCT04703686 2026-03-16Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells TherapyThe Lymphoma Academic Research OrganisationPhase 2 Completed67 enrolled
NCT02213913 2026-03-11Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasUniversity of ChicagoPhase 1/2 Completed55 enrolled 17 charts
NCT04282018 2026-02-20Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and TislelizumabBeOne MedicinesPhase 1/2 Completed97 enrolled 43 charts